Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Caspofungin for Pneumocystis Jirovecii Pneumonia in People Living With HIV/AIDS.

NCT06691321 is registered in ClinicalTrials.gov with Instituto Nacional de Enfermedades Respiratorias as lead sponsor.

NCT NCT06691321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06691321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Caspofungin for Pneumocystis Jirovecii Pneumonia in People Living With HIV/AIDS.
Lead sponsor
Instituto Nacional de Enfermedades Respiratorias
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2023
Completion date
September 1, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection, pneumocystis pneumonia